U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07746999) titled 'North Jersey Community Research Initiative (NJCRI) Study on Transgender Liver Health' on Feb. 24, 2025.
Brief Summary: Primary Objective:
Assess disparities in liver health outcomes among transgender individuals on GAHT by evaluating liver function markers (transaminases, bilirubin levels, etc), as well as liver elasticity and presence of liver steatosis or Nonalcoholic Fatty Liver Disease (NAFLD) through FibroScan. A total of 60 participants will be recruited throughout the study, with a ratio of 1:1 between transgender participants who have been on GAHT more than 6 months ( = or > 182 days), and transgender participants who have b...